Product Information

REPAGLINIDE 1 MG TABLET is a generic product labeled by NorthStar Rx LLC, priced at $0.0991 per EA under NDC 72603081101. Its NADAC has been published 56 times since Oct 29, 2025.

FDA first approved this application on Mar 22, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

REPAGLINIDE 1 MG TABLET

Repaglinide
$0.0991per EA

Strength

1 mg/1

Manufacturer

NorthStar Rx LLC

NDC

72603081101

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

REPAGLINIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA207209

FDA Approved

3/22/2023

TE Code

AB

On Market Since

4/8/2025

Pharmacological Classes

Glinide
Potassium Channel Antagonists

Price Statistics

The NADAC for REPAGLINIDE 1 MG TABLET has been published 56 times since Oct 29, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.0991 per EA
All-time high$0.1060 (Nov 11, 2026)
All-time low$0.0800 (Mar 18, 2026)
52-week high$0.1060
52-week low$0.0800
Median price$0.0887
Average price$0.0898
Largest weekly change-8.5% (Nov 19, 2025)
Weeks tracked56
Tracking sinceOct 29, 2025

Price History

1W

-6.5%

1M

+0.4%

3M

+5.8%

6M

+14.2%

1Y

-1.4%

3Y

N/A

5Y

N/A

All

-1.4%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of REPAGLINIDE 1 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for REPAGLINIDE 1 MG TABLET, manufactured by NorthStar Rx LLC, is $0.0991 per EA (NDC 72603081101), effective Nov 18, 2026.

How has the price of REPAGLINIDE 1 MG TABLET changed over time?

Over the history we have for it, the NADAC for REPAGLINIDE 1 MG TABLET has held within roughly two percent of its current level. It has been tracked across 56 weekly CMS publications since Oct 29, 2025.

What are the highest and lowest recorded NADAC prices for REPAGLINIDE 1 MG TABLET?

Since Oct 29, 2025, the NADAC for REPAGLINIDE 1 MG TABLET has ranged from a low of $0.0800 (Mar 18, 2026) to a high of $0.1060 (Nov 11, 2026), with a median of $0.0887 per EA.

Are there cheaper alternatives to REPAGLINIDE 1 MG TABLET?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as REPAGLINIDE 1 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures REPAGLINIDE 1 MG TABLET?

REPAGLINIDE 1 MG TABLET (NDC 72603081101) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.